vs

Side-by-side financial comparison of Primis Financial Corp. (FRST) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $40.7M, roughly 1.1× PETMED EXPRESS INC). Primis Financial Corp. runs the higher net margin — 16.0% vs -26.0%, a 42.0% gap on every dollar of revenue. Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs -20.9%).

Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

FRST vs PETS — Head-to-Head

Bigger by revenue
FRST
FRST
1.1× larger
FRST
$45.6M
$40.7M
PETS
Higher net margin
FRST
FRST
42.0% more per $
FRST
16.0%
-26.0%
PETS
Faster 2-yr revenue CAGR
FRST
FRST
Annualised
FRST
13.0%
-20.9%
PETS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
FRST
FRST
PETS
PETS
Revenue
$45.6M
$40.7M
Net Profit
$7.3M
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
16.0%
-26.0%
Revenue YoY
-23.3%
Net Profit YoY
200.0%
-1392.6%
EPS (diluted)
$0.30
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRST
FRST
PETS
PETS
Q1 26
$45.6M
Q4 25
$80.9M
$40.7M
Q3 25
$41.0M
$44.4M
Q2 25
$43.2M
$51.2M
Q1 25
$58.7M
$50.8M
Q4 24
$38.8M
$52.0M
Q3 24
$37.3M
$58.0M
Q2 24
$35.7M
$66.2M
Net Profit
FRST
FRST
PETS
PETS
Q1 26
$7.3M
Q4 25
$29.5M
$-10.6M
Q3 25
$6.8M
$-8.5M
Q2 25
$2.4M
$-34.2M
Q1 25
$22.6M
$-11.6M
Q4 24
$-26.2M
$-707.0K
Q3 24
$1.2M
$2.3M
Q2 24
$3.4M
$3.8M
Gross Margin
FRST
FRST
PETS
PETS
Q1 26
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Operating Margin
FRST
FRST
PETS
PETS
Q1 26
Q4 25
44.8%
-25.7%
Q3 25
21.3%
-18.9%
Q2 25
6.9%
-66.7%
Q1 25
41.9%
-11.9%
Q4 24
-123.0%
-0.9%
Q3 24
-3.1%
1.0%
Q2 24
7.8%
6.6%
Net Margin
FRST
FRST
PETS
PETS
Q1 26
16.0%
Q4 25
36.5%
-26.0%
Q3 25
16.7%
-19.2%
Q2 25
5.6%
-66.7%
Q1 25
38.6%
-22.9%
Q4 24
-100.3%
-1.4%
Q3 24
3.3%
4.0%
Q2 24
9.6%
5.7%
EPS (diluted)
FRST
FRST
PETS
PETS
Q1 26
$0.30
Q4 25
$1.19
$-0.50
Q3 25
$0.28
$-0.41
Q2 25
$0.10
$-1.65
Q1 25
$0.92
$-0.56
Q4 24
$-0.95
$-0.03
Q3 24
$0.05
$0.11
Q2 24
$0.14
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRST
FRST
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$159.9M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$427.2M
$32.8M
Total Assets
$4.3B
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRST
FRST
PETS
PETS
Q1 26
$159.9M
Q4 25
$143.6M
$26.9M
Q3 25
$63.9M
$36.1M
Q2 25
$94.1M
$41.1M
Q1 25
$57.0M
$54.7M
Q4 24
$64.5M
$50.1M
Q3 24
$77.3M
$52.0M
Q2 24
$66.6M
$46.0M
Stockholders' Equity
FRST
FRST
PETS
PETS
Q1 26
$427.2M
Q4 25
$422.9M
$32.8M
Q3 25
$382.2M
$43.1M
Q2 25
$376.4M
$51.5M
Q1 25
$375.6M
$85.1M
Q4 24
$351.8M
$96.2M
Q3 24
$381.0M
$96.4M
Q2 24
$376.0M
$93.5M
Total Assets
FRST
FRST
PETS
PETS
Q1 26
$4.3B
Q4 25
$4.0B
$88.0M
Q3 25
$4.0B
$100.3M
Q2 25
$3.9B
$109.8M
Q1 25
$3.7B
$148.7M
Q4 24
$3.7B
$144.8M
Q3 24
$4.0B
$146.0M
Q2 24
$4.0B
$152.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRST
FRST
PETS
PETS
Operating Cash FlowLast quarter
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRST
FRST
PETS
PETS
Q1 26
Q4 25
$10.8M
$-9.2M
Q3 25
$-11.4M
$-2.2M
Q2 25
$-41.0M
$-12.3M
Q1 25
$34.4M
$7.0M
Q4 24
$19.5M
$-1.2M
Q3 24
$6.1M
$7.4M
Q2 24
$52.3M
$-8.5M
Free Cash Flow
FRST
FRST
PETS
PETS
Q1 26
Q4 25
$9.0M
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$18.3M
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
FCF Margin
FRST
FRST
PETS
PETS
Q1 26
Q4 25
11.2%
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
47.3%
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Capex Intensity
FRST
FRST
PETS
PETS
Q1 26
Q4 25
2.1%
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
3.1%
1.5%
Q3 24
0.0%
2.2%
Q2 24
0.0%
1.0%
Cash Conversion
FRST
FRST
PETS
PETS
Q1 26
Q4 25
0.36×
Q3 25
-1.67×
Q2 25
-16.82×
Q1 25
1.52×
Q4 24
Q3 24
4.93×
3.18×
Q2 24
15.21×
-2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRST
FRST

Net Interest Income$32.1M70%
Noninterest Income$13.6M30%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons